Mary L. Alpaugh Department of Surgery Memorial Sloan Kettering Cancer Center Biography Publications Institution JoVE Articles Mary L. Alpaugh has not added a biography. If you are Mary L. Alpaugh and would like to personalize this page please email our Author Liaison for assistance. Publications The IL-6/JAK/Stat3 Feed-forward Loop Drives Tumorigenesis and Metastasis Neoplasia (New York, N.Y.). Jul, 2013 | Pubmed ID: 23814496 Synthesis of Purine-scaffold Fluorescent Probes for Heat Shock Protein 90 with Use in Flow Cytometry and Fluorescence Microscopy Bioorganic & Medicinal Chemistry Letters. Sep, 2011 | Pubmed ID: 21802945 Breast Carcinomatous Tumoral Emboli Can Result from Encircling Lymphovasculogenesis Rather Than Lymphovascular Invasion Oncotarget. Jun, 2010 | Pubmed ID: 21297224 Gain in Cellular Organization of Inflammatory Breast Cancer: A 3D in Vitro Model That Mimics the in Vivo Metastasis BMC Cancer. 2009 | Pubmed ID: 20028562 Molecular Plasticity of E-cadherin and Sialyl Lewis X Expression, in Two Comparative Models of Mammary Tumorigenesis PloS One. 2009 | Pubmed ID: 19675678 Relationship of Sialyl-Lewis(x/a) Underexpression and E-cadherin Overexpression in the Lymphovascular Embolus of Inflammatory Breast Carcinoma The American Journal of Pathology. Aug, 2002 | Pubmed ID: 12163386 Reversible Model of Spheroid Formation Allows for High Efficiency of Gene Delivery Ex Vivo and Accurate Gene Assessment in Vivo Human Gene Therapy. Jul, 2002 | Pubmed ID: 12133277 Comparative Oncological Studies of Feline Bronchioloalveolar Lung Carcinoma, Its Derived Cell Line and Xenograft Cancer Research. Jul, 2002 | Pubmed ID: 12097296 Cooperative Role of E-cadherin and Sialyl-Lewis X/A-deficient MUC1 in the Passive Dissemination of Tumor Emboli in Inflammatory Breast Carcinoma Oncogene. May, 2002 | Pubmed ID: 12032865 エキソビボ処理前臨床のための原発腫瘍および/ または関連した転移の応答と治療薬の臨床開発 Adriana D. Corben*1, Mohammad M. Uddin*2, Brooke Crawford3, Mohammad Farooq4, Shanu Modi5, John Gerecitano5, Gabriela Chiosis2, Mary L. Alpaugh6 1Department of Pathology, Memorial Sloan Kettering Cancer Center, 2Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, 3Department of Radiology, Weill Cornell Medical College, 4Department of Medicine, Memorial Sloan Kettering Cancer Center, 5Department of Oncology, Memorial Sloan Kettering Cancer Center, 6Department of Surgery, Memorial Sloan Kettering Cancer Center JoVE 52157 Medicine
エキソビボ処理前臨床のための原発腫瘍および/ または関連した転移の応答と治療薬の臨床開発 Adriana D. Corben*1, Mohammad M. Uddin*2, Brooke Crawford3, Mohammad Farooq4, Shanu Modi5, John Gerecitano5, Gabriela Chiosis2, Mary L. Alpaugh6 1Department of Pathology, Memorial Sloan Kettering Cancer Center, 2Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, 3Department of Radiology, Weill Cornell Medical College, 4Department of Medicine, Memorial Sloan Kettering Cancer Center, 5Department of Oncology, Memorial Sloan Kettering Cancer Center, 6Department of Surgery, Memorial Sloan Kettering Cancer Center JoVE 52157 Medicine
